Streetbeat News

Equity Actions

LL

F9 Investments, owning 8.85% of LL Flooring, sent a letter to shareholders correcting alleged distortions and attacks by LL Flooring's board. F9 criticizes the board for poor performance and urges shareholders to vote for F9's director nominees to restore value.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:23 am

NIVF

NewGenIvf has provided an update on its potential reverse merger with COVIRIX. According to the term sheet, NewGen will issue 102.89 million ordinary shares to COVIRIX for a 100% equity interest in COVIRIX, valued at $617.34 million.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:10 am

ALTR

Altair (NASDAQ:ALTR) has been added to the S&P MidCap 400, marking a significant growth milestone for the company. This inclusion reflects Altair's strong and steady growth in computational intelligence, simulation and design, data analytics, AI, and high-performance computing.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:03 am

HOLO

MicroCloud Hologram has entered into Convertible Note Purchase Agreements with investors for $28 million on June 18.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:32 am

LAB

Standard Biotools has filed for an offering of up to 105.1 million common shares by the selling securityholders, as per the S-3 filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:27 am

NUTX

Nutex Health has received shareholder approval for a reverse stock split ranging from 1-for-2 to 1-for-16, aiming to comply with NASDAQ listing requirements.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:15 am

ALOT

AstroNova, Inc. has appointed Thomas DeByle as the new Chief Financial Officer, replacing the retiring David S. Smith. This leadership change is expected to influence the company's financial strategies and operations.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 9:25 am

MOR

NVS

Novartis has announced plans to delist MorphoSys from the Frankfurt Stock Exchange and NASDAQ following its acquisition. Novartis will initiate a squeeze-out of MorphoSys' minority shareholders and merge MorphoSys into Novartis. The delisting and merger are expected to be completed by Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 7:13 am

BEST

BEST Inc. (NYSE:BEST) has announced a $54.2 million merger deal with BEST Global Partners, resulting in the company going private and delisting from the NYSE. The merger offers a premium to shareholders and is expected to close in Q3 2024, subject to customary conditions and shareholder approval.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 7:10 am

AZO

AutoZone's Board of Directors has approved an additional $1.5 billion for share repurchases, bringing the total authorized amount to $39.2 billion since the program's inception in 1998.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 6:21 am